Professional Documents
Culture Documents
Emilio Polo Ledesma
Emilio Polo Ledesma
Emilio Polo Ledesma
Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research
Institute, Edinburgh, EH16 4TJ, UK
Cite this as: BMJ 2017;359:j5024
http://dx.doi.org/10.1136/bmj.j5024
Accepted: 16 October 2017
RESULTS
The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and
17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often
associated with benefit than harm for a range of health outcomes across exposures including high versus low, any
versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and
some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a
day versus none, including all cause mortality (relative risk 0.83, 95% confidence interval 0.83 to 0.88),
cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90).
P Personas - Pacientes
I E Intervención - Exposición
C Comparación - Control
O Outcome
Qué evidencia existe, desde el
siglo 17 hasta nuestros días, de
la asociación que existe entre
consumo diario de café y la
incidencia de Diabetes 2, en
personas mayores de 50 años.
Revisión
Sistemática
Meta-análisis
IMRAD
The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers
G Y Lai*, S J Weinstein, D Albanes, P R Taylor, K A McGlynn, J Virtamo, R Sinha, and N D Freedman.
www.bjcancer.com | DOI:10.1038/bjc.2013.405
Mortalidad Ca Higado
SI NO Total Risk
SI 185 26545 26730 70
Café